Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhito Uezono

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 27, 2021
Inhibition of endothelin A receptor by a novel, selective receptor antagonist enhances morphine-induced analgesia: Possible functional interaction of dimerized endothelin A and μ-opioid receptorsYui Kuroda, Miki Nonaka, Yuji Kamikubo, et al.
Japanese Journal of Clinical Oncology|July 30, 2022
Prevention of delirium with agitation by yokukansan in older adults after cancer surgeryRyoichi Sadahiro, Saho Wada, Yutaka J Matsuoka, et al.
Scientific Reports|January 19, 2020
The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositisKanako Miyano, Moeko Eto, Suzuro Hitomi, et al.
Scientific Reports|November 10, 2020
Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositisKanako Miyano, Moeko Eto, Suzuro Hitomi, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening ProtocolFumika Karaki, Taro Takamori, Koumei Kawakami, et al.
Biochemical and Biophysical Research Communications|November 3, 2020
Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridineTomohisa Mori, Yoshinori Takemura, Takamichi Arima, et al.
Molecular Pain|October 24, 2017
Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive toleranceTomohisa Mori, Naoko Kuzumaki, Takamichi Arima, et al.
Plos One|April 9, 2015
Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivoMasami Suzuki, Fumiko Chiwaki, Yumi Sawada, et al.
Psychiatry and Clinical Neurosciences|August 6, 2025
Metabolome Profiling of Yokukansan in Preventing Postoperative Delirium in Elderly Cancer Patients: A Reverse Translational StudyRyoichi Sadahiro, Katsuya Ohbuchi, Taiki Nakaya, et al.
Chemical & Pharmaceutical Bulletin|July 31, 2024
Structure-Activity Relationship Study of CYM51010, an agonist for the µ-δ Opioid Receptor HeterodimerAyaka Watanabe, Shuma Yamada, Haruka Yoshida, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 27, 2021
Inhibition of endothelin A receptor by a novel, selective receptor antagonist enhances morphine-induced analgesia: Possible functional interaction of dimerized endothelin A and μ-opioid receptorsYui Kuroda, Miki Nonaka, Yuji Kamikubo, et al.
Japanese Journal of Clinical Oncology|July 30, 2022
Prevention of delirium with agitation by yokukansan in older adults after cancer surgeryRyoichi Sadahiro, Saho Wada, Yutaka J Matsuoka, et al.
Scientific Reports|January 19, 2020
The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositisKanako Miyano, Moeko Eto, Suzuro Hitomi, et al.
Scientific Reports|November 10, 2020
Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositisKanako Miyano, Moeko Eto, Suzuro Hitomi, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening ProtocolFumika Karaki, Taro Takamori, Koumei Kawakami, et al.
Biochemical and Biophysical Research Communications|November 3, 2020
Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridineTomohisa Mori, Yoshinori Takemura, Takamichi Arima, et al.
Molecular Pain|October 24, 2017
Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive toleranceTomohisa Mori, Naoko Kuzumaki, Takamichi Arima, et al.
Plos One|April 9, 2015
Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivoMasami Suzuki, Fumiko Chiwaki, Yumi Sawada, et al.
Psychiatry and Clinical Neurosciences|August 6, 2025
Metabolome Profiling of Yokukansan in Preventing Postoperative Delirium in Elderly Cancer Patients: A Reverse Translational StudyRyoichi Sadahiro, Katsuya Ohbuchi, Taiki Nakaya, et al.
Chemical & Pharmaceutical Bulletin|July 31, 2024
Structure-Activity Relationship Study of CYM51010, an agonist for the µ-δ Opioid Receptor HeterodimerAyaka Watanabe, Shuma Yamada, Haruka Yoshida, et al.
Pageof 19